$238K - $327K
As the Senior Director, Head of Global Pricing and Access (V&A) for Alzheimer’s Disease, you will be at the forefront of Biogen's market access and pricing strategies, with a focus on our Alzheimer’s Disease pipeline. You will guide the development and execution of value and access strategies, ensuring they align with both development and commercialization efforts. This role involves leading V&A engagement with external stakeholders and embedding V&A considerations into our strategic framework. Your work will includemapping out the Value and Access Strategic Plan,collaborating with Value Evidence Strategy team toidentifyevidence priorities, as well ascrafting innovative access schemesanddeveloping pricing policiesin an evolving environment. Reporting directly to the Head of Global Pricing & Access, you will play a pivotal role in shaping the future of Alzheimer’s treatments, ensuring they reach patients effectively and sustainably.
You are a visionary leader with a deep understanding of market access and pricing strategies, particularly in the global healthcare landscape. Yourstrong communicationskills enable you to convey complex information clearly to senior leaders and external stakeholders. You have a collaborative spirit, thriving in cross-functional and cross-regionalteams where consensus-building and strategic alignment are key.You are passionate about making a difference in the lives of patients through innovative access solutions and evidence-based approaches.
Job Level: Management
Biogen is a leading biotech company focused on neurological diseases, developing innovative medicines, biologics, small molecules, and biosimilars.
View company profile →